Related Experiment Video
Updated: Sep 18, 2025

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
LncRNA MEG3/CTCF-CXCR4 axis functions in the regulation of breast cancer cell migration
Gusai Elhassan1,2, Xiangxue Bu1, Jiaxin Liu1
1Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Abstract:
Loss or decreased expression of lncRNA MEG3 is a frequent event in the progression of many different malignancies. Overexpression of MEG3 in breast cancer cell lines MCF7 or MDA-MB-231 prevented cell migration, whereas depletion of MEG3 in human mammary epithelial cell line MCF10A strikingly promoted cell migration. As RNA-protein interactions are vital for RNA to function, RNP assembled on MEG3 in vivo was purified using affinity purification followed by mass spectrometry, which revealed ∼600 proteins with the potential to interact with MEG3. Bioinformatic analysis on RNA-seq data from MCF7 with MEG3 overexpression and MCF10A with MEG3 depletion led to the identification of CXCR4 as the major downstream mediator negatively regulated by MEG3 that facilitated breast cancer cell migration. In addition, the chromatin regulator CTCF emerged as the MEG3-binding protein that might regulate CXCR4 expression after comparison of proteins presenting in MEG3 lncRNP to ChIP-seq data and GPSAdb data of CXCR4. Further evidence was provided to show CTCF upregulated the expression of CXCR4 at transcriptional level, whereas co-expression of MEG3 with CTCF abolished transcriptional activation of CXCR4. Overall, our study pinpoints the importance of MEG3/CTCF-CXCR4 axis in regulating migration of breast cancer cells and provides novel insight into the mechanism of lncRNA MEG3 in cancer development.
Insights
Loss of MEG3 long noncoding RNA promotes breast cancer cell migration. MEG3 interacts with CTCF to downregulate CXCR4, revealing a key axis in cancer progression.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Decreased expression of the long noncoding RNA (lncRNA) MEG3 is common in many cancers.
- MEG3 influences cancer cell behavior, including migration, in various cell lines.
Purpose of the Study:
- To investigate the role of MEG3 in breast cancer cell migration.
- To identify downstream mediators and interacting proteins of MEG3.
- To elucidate the molecular mechanism by which MEG3 regulates breast cancer progression.
Main Methods:
- Purification of MEG3-bound ribonucleoprotein (RNP) complexes via affinity purification followed by mass spectrometry.
- Bioinformatic analysis of RNA-sequencing data from breast cancer cell lines with altered MEG3 expression.
- Chromatin immunoprecipitation sequencing (ChIP-seq) and Gene Protein-Sequence Association database (GPSAdb) analysis.
Main Results:
- MEG3 overexpression inhibited migration in MCF7 and MDA-MB-231 cells; MEG3 depletion promoted migration in MCF10A cells.
- CXCR4 was identified as a key downstream mediator negatively regulated by MEG3.
- The chromatin regulator CTCF was identified as a MEG3-binding protein that upregulates CXCR4 transcription; MEG3 co-expression with CTCF abolished this upregulation.
Conclusions:
- The MEG3/CTCF-CXCR4 axis is crucial for regulating breast cancer cell migration.
- This study provides novel insights into the mechanism of lncRNA MEG3 in cancer development and progression.
Related Concept Videos
Cancer Cell Migration through Invadopodia
lncRNA - Long Non-coding RNAs
Chemotaxis and Direction of Cell Migration
Cytoskeletal Coordination in Cell Migration
Master Transcription Regulators
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

